AstraZeneca Pharma India Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	4,486	5,361	5,056	5,003	4,484
Cash & Short-Term Investments	4,486	5,361	5,056	5,003	4,484
Cash Growth	-16.32%	6.05%	1.04%	11.58%	27.27%
Accounts Receivable	2,137	1,849	1,531	1,075	858.9
Other Receivables	-	143.6	160.4	105.1	121.8
Receivables	2,137	1,995	1,693	1,181	981.6
Inventory	10,273	5,485	2,279	1,902	1,402
Prepaid Expenses	-	142.1	109.6	117.7	108.2
Other Current Assets	503	439.6	190	150.4	80.5
Total Current Assets	17,399	13,424	9,327	8,355	7,057
Property, Plant & Equipment	1,175	635.8	648.4	701.9	766.9
Other Intangible Assets	-	6.6	21.1	-	-
Long-Term Deferred Tax Assets	378	415.6	212.5	206.7	163
Other Long-Term Assets	939	698.6	568.5	576.6	574.9
Total Assets	19,891	15,181	10,780	9,849	8,566
Accounts Payable	7,827	4,563	1,965	2,279	1,904
Accrued Expenses	-	602.7	767.2	852.3	785.3
Current Portion of Leases	139.1	62.8	18.1	35.2	36.1
Current Income Taxes Payable	54.1	106.4	66.6	24.2	49.4
Current Unearned Revenue	-	722.4	490.5	398	306.9
Other Current Liabilities	1,798	972.7	263.7	250.8	244.4
Total Current Liabilities	9,818	7,030	3,571	3,839	3,327
Long-Term Leases	967.5	294.5	27.8	36.9	50.2
Pension & Post-Retirement Benefits	-	53.7	44.4	69	48.2
Other Long-Term Liabilities	377.5	99.5	17.7	16.6	26.8
Total Liabilities	11,163	7,478	3,661	3,962	3,452
Common Stock	50	50	50	50	50
Retained Earnings	-	6,859	6,313	5,088	4,321
Comprehensive Income & Other	8,678	795	756.4	749.2	743
Shareholders' Equity	8,728	7,704	7,119	5,887	5,114
Total Liabilities & Equity	19,891	15,181	10,780	9,849	8,566
Total Debt	1,107	357.3	45.9	72.1	86.3
Net Cash (Debt)	3,380	5,004	5,010	4,931	4,398
Net Cash Growth	-32.46%	-0.11%	1.59%	12.13%	29.27%
Net Cash Per Share	135.19	200.16	200.39	197.25	175.92
Filing Date Shares Outstanding	25	25	25	25	25
Total Common Shares Outstanding	25	25	25	25	25
Working Capital	7,581	6,394	5,756	4,515	3,730
Book Value Per Share	349.08	308.14	284.77	235.48	204.56
Tangible Book Value	8,728	7,697	7,098	5,887	5,114
Tangible Book Value Per Share	349.08	307.88	283.92	235.48	204.56
Land	-	4.9	4.9	4.9	4.9
Buildings	-	427	427	421.3	415.2
Machinery	-	1,155	1,208	1,154	1,082
Construction In Progress	-	-	2.7	13.3	22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.